CD14 overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CD14 overexpression	Hodgkin Lymphoma	CD14 overexpression	Hodgkin Lymphoma	nivolumab + brentuximab vedotin Sensitive: C3 – Early Trials nivolumab + brentuximab vedotin Sensitive : C3	nivolumab + brentuximab vedotin Sensitive: C3 – Early Trials nivolumab + brentuximab vedotin Sensitive : C3
CD14 overexpression	Acute Myelogenous Leukemia	CD14 overexpression	Acute Myelogenous Leukemia	venetoclax + palbociclib Sensitive: C3 – Early Trials venetoclax + palbociclib Sensitive : C3	venetoclax + palbociclib Sensitive: C3 – Early Trials venetoclax + palbociclib Sensitive : C3

Associations